Wendy Carruthers net worth and biography

Wendy Carruthers Biography and Net Worth

Wendy Carruthers is our senior vice president, human resources, a position she has held since December 2012. In this role, she is responsible for overseeing the Company’s human resources activities globally, including human resources operations and services, total rewards, talent management, diversity and inclusion and community engagement. Prior to her current role, Ms. Carruthers served as the head of human resources on an interim basis from August 2012 to November 2012, as well as our vice president of global talent management from January 2011 to November 2012. Ms. Carruthers has been with Boston Scientific since 2004 and has held various positions such as, vice president of human resources for our Europe, Middle East and Africa region; vice president of human resources for Europe and director of human resources for Europe. Also, Ms. Carruthers serves as a Co-Chair of our Global Council for Inclusion. Prior to joining Boston Scientific, Ms. Carruthers was vice president of human resources, Europe for Cable & Wireless. Ms. Carruthers holds a B.A. First Class Honors Degree in Modern Languages from the University of Salford and is a Fellow of the Chartered Institute of Personnel and Development. She serves on the Board of Envista Holdings Corporation and the Boston Scientific Foundation, and she is a member of the Greater Boston Food Bank Emeriti Board.

What is Wendy Carruthers' net worth?

The estimated net worth of Wendy Carruthers is at least $4.33 million as of September 15th, 2022. Ms. Carruthers owns 109,913 shares of Boston Scientific stock worth more than $4,330,572 as of September 29th. This net worth estimate does not reflect any other assets that Ms. Carruthers may own. Learn More about Wendy Carruthers' net worth.

How do I contact Wendy Carruthers?

The corporate mailing address for Ms. Carruthers and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected] Learn More on Wendy Carruthers' contact information.

Has Wendy Carruthers been buying or selling shares of Boston Scientific?

In the last ninety days, Wendy Carruthers has sold $916,800.00 in Boston Scientific stock. Most recently, Wendy Carruthers sold 7,500 shares of the business's stock in a transaction on Thursday, September 15th. The shares were sold at an average price of $42.21, for a transaction totalling $316,575.00. Following the completion of the sale, the executive vice president now directly owns 109,913 shares of the company's stock, valued at $4,639,427.73. Learn More on Wendy Carruthers' trading history.

Who are Boston Scientific's active insiders?

Are insiders buying or selling shares of Boston Scientific?

During the last twelve months, Boston Scientific insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $1,049,500.00. During the last twelve months, insiders at the medical equipment provider sold shares 28 times. They sold a total of 667,188 shares worth more than $28,402,931.19. The most recent insider tranaction occured on September, 15th when EVP Wendy Carruthers sold 7,500 shares worth more than $316,575.00. Insiders at Boston Scientific own 0.7 % of the company. Learn More about insider trades at Boston Scientific.

Information on this page was last updated on 9/15/2022.

Wendy Carruthers Insider Trading History at Boston Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2022Sell7,500$42.21$316,575.00109,913View SEC Filing Icon  
8/15/2022Sell7,500$42.03$315,225.00117,413View SEC Filing Icon  
7/18/2022Sell7,500$38.00$285,000.00124,913View SEC Filing Icon  
6/24/2022Sell7,500$38.00$285,000.00132,413View SEC Filing Icon  
5/16/2022Sell7,500$39.43$295,725.00139,913View SEC Filing Icon  
4/14/2022Sell7,500$44.47$333,525.00147,413View SEC Filing Icon  
12/15/2021Sell3,321$40.83$135,596.43View SEC Filing Icon  
11/15/2021Sell3,321$42.18$140,079.78View SEC Filing Icon  
10/15/2021Sell3,322$43.58$144,772.76View SEC Filing Icon  
9/15/2021Sell3,321$44.88$149,046.48164,573View SEC Filing Icon  
7/15/2021Sell3,321$42.42$140,876.82171,216View SEC Filing Icon  
6/15/2021Sell3,322$42.70$141,849.40174,537View SEC Filing Icon  
8/26/2020Sell10,200$39.16$399,432.00178,973View SEC Filing Icon  
12/13/2019Sell24,220$45.03$1,090,626.60168,848View SEC Filing Icon  
3/11/2019Sell29,412$39.63$1,165,597.56200,751View SEC Filing Icon  
11/2/2018Sell1,500$36.64$54,960.00View SEC Filing Icon  
8/3/2017Sell12,433$26.75$332,582.75View SEC Filing Icon  
5/28/2015Sell42,281$17.91$757,252.71View SEC Filing Icon  
5/30/2013Sell25,001$9.16$229,009.16View SEC Filing Icon  
See Full Table

Wendy Carruthers Buying and Selling Activity at Boston Scientific

This chart shows Wendy Carruthers's buying and selling at Boston Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Boston Scientific Company Overview

Boston Scientific logo
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Read More

Today's Range

Now: $39.32
Low: $38.54
High: $39.50

50 Day Range

MA: $40.86
Low: $37.96
High: $43.46

2 Week Range

Now: $39.32
Low: $34.98
High: $47.49

Volume

286,927 shs

Average Volume

6,205,551 shs

Market Capitalization

$56.21 billion

P/E Ratio

67.79

Dividend Yield

N/A

Beta

0.85